Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Projections are in Place for the Scleroderma Market Between 2024-2033?

In recent times, the size of the scleroderma market has seen significant growth. The market, which stands at $2.15 billion in 2023, is predicted to rise to $2.31 billion in 2024, with a compound annual growth rate (CAGR) of 7.4%. The enhancement in the past years has been linked to progress in diagnosis techniques, research in immunology, developments in therapy, enhanced awareness and education, as well as studies in genetics.

The market value of scleroderma is predicted to rise significantly in the coming years. It is set to increase to $2.97 billion by 2028, expanding at a compound annual growth rate (CAGR) of 6.5%. This market growth in the projected timeline is due to factors such as biological therapies, precision medicine, stem cell therapies, research in genomics and biomarkers, and global partnerships. Predominant trends during this period will be digital health solutions, emphasis on microbiome, patient-centric care, regenerative medicine, and health equality and accessibility.

Claim Your Free Sample of the Global Scleroderma Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12615&type=smp

What Are the Major Factors Contributing to the scleroderma Market Expansion?

The scleroderma market is being propelled forward by an increased occurrence of this medical condition. Scleroderma is a long-term autoimmune disease distinguished by irregular collagen growth, a component that constitutes the framework of skin and other body tissues. This condition develops due to an unchecked immune response, which could be instigated by various environmental elements. The surge in scleroderma cases necessitates the refinement in identifying and addressing this condition. The role of scleroderma therapeutics in handling the disease and alleviating symptoms is pivotal. These therapeutics work by controlling the immune response and minimizing contact with environmental hazards. For example, data from Karger Publishers in Switzerland showed that, in June 2022, scleroderma affected 19,000 individuals in the UK and 2.5 million people globally. Moreover, a study disclosed by the Oxford Academic Press in July 2021 revealed that the worldwide scleroderma prevalence stood at 17.6 cases per 100,000 people, with an incidence rate of 1.4 cases per 100,000 person-years. From this standpoint, the upswing in scleroderma occurrence is fueling the scleroderma market.

Which Key Segments Shape the Scleroderma Market?

1) By Treatment: Medication, Surgery, Other Treatments

2) By Indication: Systemic Scleroderma, Localized Scleroderma

3) By End User: Hospital, Pharmaceutical Stores, Other End Users

What Are the Transformative Trends Influencing the Scleroderma Market?

Creating innovative therapies has emerged as a significant trend in the scleroderma market. To remain competitive within the market, key players are focusing on the development of new medication to efficiently manage the symptoms of scleroderma. For example, in April 2022, the US-based biotherapeutics manufacturer, Tyr Pharma Inc. was granted regulatory consent for its new drug efzofitimod, specifically designed for systemic sclerosis-related interstitial lung disease, by the US Food and Drug Administration. This groundbreaking drug is the first of its kind, functioning as an immunomodulator to manage and tone down the immune response by influencing the neuropilin-2 (NRP2) receptor, with the aim to alleviate scleroderma symptoms. In addition to this, Efzofitimod has been found to also target the same immune cells that have been linked to the development of SSc-ILD (interstitial lung disease correlated with systemic sclerosis) and pulmonary sarcoidosis. This led to a decrease in pro-inflammatory markers within a clinical trial featuring patients that suffer from pulmonary sarcoidosis.

Order Now for Fast Delivery of Your Scleroderma Market Report!

https://www.thebusinessresearchcompany.com/report/scleroderma-global-market-report

What Regions Are Leading the Growth Trajectory of the Scleroderma Market?

North America was the largest region in the scleroderma market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the scleroderma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Scleroderma Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the scleroderma market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Scleroderma Market Include

1. Scleroderma Market Executive Summary

2. Scleroderma Market Segments

3. Scleroderma Market Size And Template Market Growth Rate

4. Key Scleroderma Market Trends

5. Major Scleroderma Market Drivers

……

25. Key Mergers And Acquisitions In The Scleroderma Market

26. Top Scleroderma Companies

27. Scleroderma Market Opportunities And Strategies

28. Scleroderma Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Dermatology OTC Medications Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatology-otc-medications-global-market-report

Dermatology Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatology-devices-global-market-report

Dermatology Endoscopy Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/dermatology-endoscopy-devices-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: